Feature

Looking for lower Medicare drug costs? Ask your pharmacist for the cash price


 


“The Department has received inquiries related to entities withholding cost-saving information from consumers, which sometimes results in an insured [patient] paying more for pharmacy benefits than the actual cost of such pharmacy benefits,” the department said in April.

Illinois and Ohio state legislators are considering bills to make such restrictions illegal, and similar legislation has been introduced in the U.S. Senate.

“If we didn’t have these gag clauses, there would not be a need for the legislation and policy changes movement that’s going on in the country,” said Garth Reynolds, executive director of the Illinois Pharmacists Association.

KHN’s coverage of prescription drug development, costs and pricing is supported by the Laura and John Arnold Foundation. Kaiser Health News is a nonprofit national health policy news service. It is an editorially independent program of the Henry J. Kaiser Family Foundation that is not affiliated with Kaiser Permanente.

Pages

Recommended Reading

Two more and counting: Suicide in medical trainees
MDedge Hematology and Oncology
FDA’s Gottlieb floats ideas on Medicare drug coverage
MDedge Hematology and Oncology
ABIM, ASCO to build new pathway for maintenance of board certification
MDedge Hematology and Oncology
Drugmakers blamed for blocking generics have cost U.S. billions
MDedge Hematology and Oncology
Congress passes ‘right to try’ legislation
MDedge Hematology and Oncology
CMS proposes inpatient payment model for CAR T therapies
MDedge Hematology and Oncology
MDedge Daily News: Keeping patients summer safe
MDedge Hematology and Oncology
Peer mentorship, groups help combat burnout in female physicians
MDedge Hematology and Oncology
Geriatric assessments enhance patient care in advanced cancer
MDedge Hematology and Oncology
Metastatic colorectal cancer chemo costs double in Washington vs. British Columbia
MDedge Hematology and Oncology